This article investigated the effect of weight change after giving birth on cardiometabolic outcomes in women with gestational diabetes (GDM). The authors concluded that weight loss and the prevention of further weight gain is beneficial to these women.

This article investigated the safety and effectiveness of liquid and lyophilized (freeze-dried powder) albiglutide (Tanzeum) in the management of type 2 diabetes (T2D). The authors concluded that the two forms of the drug were similarly effective and safe in these patients.

This study compared the effectiveness of abatacept (Orencia) and tocilizumab (Actemra) in patients with rheumatoid arthritis (RA) who had previously taken anti TNF therapy. The authors concluded that both of these drugs led to a significant improvement in disease activity in both treatment groups. 

This article investigated the rate of vision loss at 2 years among eyes with center involved-diabetic macular edema (CI-DME; vision loss in people with diabetes) initially managed with aflibercept (Eylea), laser photocoagulation (LP) or observation. The authors concluded that there was no significant difference in vision loss at 2 years between the three initial treatments or if aflibercept was given only when sight worsened. 

This study examined the role of physical activity in rheumatoid arthritis (RA). The authors concluded that patients with RA are mostly active at light intensities. Light physical activity was found to reduce cardiovascular risk and also improved RA outcomes. 

This trial is examining the effectiveness of alternating doses of SAR341402 and insulin aspart (Novolog) compared with a continuous dose of insulin aspart in patients with type 1 diabetes (T1D).

The main outcomes to be measured will be the similarity between the two drugs and side effects. This trial is recruiting across the United States.

This article investigated the safety and effectiveness of higher doses of dulaglutide (Trulicity) in the management of type 2 diabetes (T2DM) in patients on metformin (Glucophage). The authors concluded that the higher doses of dulaglutide are effective and safe in these patients.

The aim of this study was to compare the effectiveness of ipragliflozin compared to metformin in improving blood sugar control and reducing fat on organs in patients with type 2 diabetes (T2D) treated with sitagliptin. The main finding of the study was that ipragliflozin had greater reductions in fat but metformin had better blood sugar control.

This study investigated the effectiveness of denosumab (Prolia) in rheumatoid arthritis (RA).

They found that this treatment reduces joint damage and improves bone mineral density in these patients.